Prediabetes and associated disorders

Prediabetes represents an elevation of plasma glucose above the normal range but below that of clinical diabetes. Prediabetes includes individuals with IFG, IGT, IFG with IGT and elevated HbA1c levels. Insulin resistance and β-cell dysfunction are characteristic of this disorder. The diagnosis of prediabetesis is vital as both IFG and IGT are indeed well-known risk factors for type 2 diabetes with a greater risk in the presence of combined IFG and IGT. Furthermore, as will be illustrated in this review, prediabetes is associated with associated disorders typically only considered in with established diabetes. These include cardiovascular disease, periodontal disease, cognitive dysfunction, microvascular disease, blood pressure abnormalities, obstructive sleep apnea, low testosterone, metabolic syndrome, various biomarkers, fatty liver disease, and cancer. As the vast majority of individuals with prediabetes are unaware of their diagnosis, it is therefore vital that the associated conditions are identified, particularly in the presence of mild hyperglycemia, so they may benefit from early intervention.

[1]  A. Jacobson,et al.  Diabetes and cognitive performance: a story that is still unfolding , 2011, Diabetologia.

[2]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[3]  Sidi Yechezkel,et al.  Fasting glucose levels within the high normal range predict cardiovascular outcome. , 2012, American heart journal.

[4]  S. Redline,et al.  Sleep-Disordered Breathing and Impaired Glucose Metabolism in Normal-Weight and Overweight/Obese Individuals , 2008, Diabetes Care.

[5]  M. Jørgensen,et al.  Cardiovascular Risk Stratification and Management in Pre-Diabetes , 2014, Current Diabetes Reports.

[6]  B. Mokhlesi,et al.  The effect of continuous positive airway pressure on glucose control in diabetic patients with severe obstructive sleep apnea , 2005, Sleep and Breathing.

[7]  W. Herman,et al.  Physical Function Limitations Among Middle-Aged and Older Adults With Prediabetes , 2013, Diabetes Care.

[8]  Y. Khader,et al.  Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study , 2013, Journal of family & community medicine.

[9]  Merlin C. Thomas,et al.  Low testosterone levels are common and associated with insulin resistance in men with diabetes. , 2008, The Journal of clinical endocrinology and metabolism.

[10]  Roy Taylor,et al.  Periodontitis and diabetes: a two-way relationship , 2011, Diabetologia.

[11]  S. Haffner,et al.  Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study. , 2005, Diabetes care.

[12]  W. White How well does ambulatory blood pressure predict target-organ disease and clinical outcome in patients with hypertension? , 1999, Blood pressure monitoring.

[13]  S. Tesfaye,et al.  Autonomic dysfunction and circadian blood pressure variations in people with impaired glucose tolerance , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[14]  A. Shankar,et al.  Markers of Sleep-Disordered Breathing and Prediabetes in US Adults , 2012, International journal of endocrinology.

[15]  Harry Whitmore,et al.  Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. , 2010, American journal of respiratory and critical care medicine.

[16]  E. Raftery,et al.  CIRCADIAN VARIATION OF BLOOD-PRESSURE , 1978, The Lancet.

[17]  E. Barrett-Connor,et al.  Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. , 2000, Diabetes care.

[18]  P. Lévy,et al.  Sleep, sleep-disordered breathing and metabolic consequences , 2009, European Respiratory Journal.

[19]  J. Murabito,et al.  Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. , 2008, Journal of the American College of Cardiology.

[20]  F. Greenway,et al.  Cardio Vascular Diabetology Open Access or I G in a L I N Ve St I G at Io N , 2022 .

[21]  O. Schnell,et al.  Impaired glucose tolerance, diabetes, and cardiovascular disease. , 2006, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[22]  Ralph B D'Agostino,et al.  Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study. , 2002, Diabetes care.

[23]  Lippincott Williams Wilkins,et al.  Higher glucose levels associated with lower memory and reduced hippocampal microstructure , 2014, Neurology.

[24]  David Kelley,et al.  Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes , 2009, Diabetes Care.

[25]  J. Concato,et al.  Obstructive sleep apnea as a risk factor for type 2 diabetes. , 2009, The American journal of medicine.

[26]  D. Sica What are the influences of salt, potassium, the sympathetic nervous system, and the renin-angiotensin system on the circadian variation in blood pressure? , 1999, Blood pressure monitoring.

[27]  Ross J. Harris,et al.  Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. , 2009, Diabetes care.

[28]  R. Vettor,et al.  Effects of acute hyperinsulinemia on testosterone serum concentrations in adult obese and normal-weight men. , 1997, Metabolism: clinical and experimental.

[29]  J. Shaw,et al.  Relation between fasting glucose and retinopathy for diagnosis of diabetes: three population-based cross-sectional studies , 2008, The Lancet.

[30]  W. Post,et al.  Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events in an adult population: MESA (Multi-Ethnic Study of Atherosclerosis). , 2011, Journal of the American College of Cardiology.

[31]  D. Jacobs,et al.  Periodontal infection, impaired fasting glucose and impaired glucose tolerance: results from the Continuous National Health and Nutrition Examination Survey 2009-2010. , 2014, Journal of clinical periodontology.

[32]  T. Valle,et al.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.

[33]  G. Biessels Intensive glucose lowering and cognition in type 2 diabetes , 2011, The Lancet Neurology.

[34]  J. Chiasson,et al.  Reducing cardiovascular risk factors in patients with prediabetes , 2011 .

[35]  S. Yusuf,et al.  Effect of Insulin Glargine and n-3FA on Carotid Intima-Media Thickness in People With Dysglycemia at High Risk for Cardiovascular Events , 2013, Diabetes Care.

[36]  A. Flyvbjerg,et al.  Periodontitis is associated with aggravation of prediabetes in Zucker fatty rats. , 2007, Journal of periodontology.

[37]  D. Levy,et al.  Coronary artery calcification in type 2 diabetes and insulin resistance: the framingham offspring study. , 2002, Diabetes care.

[38]  P. Lavie,et al.  Contributions of hypoxia and respiratory disturbance index to sympathetic activation and blood pressure in obstructive sleep apnea syndrome. , 1998, American journal of hypertension.

[39]  Lawrence Joseph,et al.  The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. , 2010, Journal of the American College of Cardiology.

[40]  E. Ferrannini Definition of intervention points in prediabetes. , 2014, The lancet. Diabetes & endocrinology.

[41]  C. Kahn,et al.  Insulin Action in Brain Regulates Systemic Metabolism and Brain Function , 2014, Diabetes.

[42]  T. Tanridag,et al.  Evaluation of peripheral and autonomic neuropathy among patients with newly diagnosed impaired glucose tolerance , 2008, Diabetes/metabolism research and reviews.

[43]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[44]  B. Frier,et al.  Diabetes and cognitive dysfunction , 2012, The Lancet.

[45]  Sudha Seshadri,et al.  Association of Metabolic Dysregulation With Volumetric Brain Magnetic Resonance Imaging and Cognitive Markers of Subclinical Brain Aging in Middle-Aged Adults , 2011, Diabetes Care.

[46]  H. Kramer Screening for kidney disease in adults with diabetes and prediabetes , 2005, Current opinion in nephrology and hypertension.

[47]  Paul M. Ridker,et al.  Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein , 2009 .

[48]  A. Peters,et al.  Identification of Serum Metabolites Associated With Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach , 2013, Diabetes.

[49]  S. Fowler,et al.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .

[50]  B. Billah,et al.  Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials , 2011, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[51]  J. Mckinlay,et al.  Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. , 2000, Diabetes care.

[52]  E. Boyko,et al.  Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. , 2004, Diabetes care.

[53]  Christian Gieger,et al.  Novel biomarkers for pre-diabetes identified by metabolomics , 2012, Molecular systems biology.

[54]  Claude Bouchard,et al.  Short Sleep Duration is Associated with Reduced Leptin Levels and Increased Adiposity: Results from the Québec Family Study , 2007, Obesity.

[55]  Matteo Anselmino,et al.  Diabetes, prediabetes and cardiovascular risk , 2010, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[56]  S. Yusuf,et al.  Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study , 2010, Diabetologia.

[57]  J. Ficker,et al.  The Effect of Continuous Positive Airway Pressure Treatment on Insulin Sensitivity in Patients with Obstructive Sleep Apnoea Syndrome and Type 2 Diabetes , 2004, Respiration.

[58]  J. Røislien,et al.  Type 2 diabetes and pre-diabetes are associated with obstructive sleep apnea in extremely obese subjects: A cross-sectional study , 2011, Cardiovascular diabetology.

[59]  N. Cheng,et al.  Effect of Hypoxia on Blood Glucose, Hormones, and Insulin Receptor Functions in Newborn Calves , 1997, Pediatric Research.

[60]  T. Wong,et al.  Retinal Vascular Changes in Pre-Diabetes and Prehypertension , 2007, Diabetes Care.

[61]  E. Ding,et al.  Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. , 2009, JAMA.

[62]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[63]  Vilmundur Gudnason,et al.  Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death , 2011 .

[64]  R Smith,et al.  PubMed Central: creating an Aladdin's cave of ideas , 2001, BMJ : British Medical Journal.

[65]  V. Mootha,et al.  Metabolite profiles and the risk of developing diabetes , 2011, Nature Medicine.

[66]  Antonio Avallone,et al.  New perspective for an old antidiabetic drug: metformin as anticancer agent. , 2014, Cancer treatment and research.

[67]  R. Collins,et al.  Statins and diabetes – Authors' reply , 2008, The Lancet.

[68]  Francesco Portaluppi,et al.  Circadian variation of blood pressure: the basis for the chronotherapy of hypertension. , 2007, Advanced drug delivery reviews.

[69]  K. Borch-Johnsen,et al.  HbA1c as predictor of all-cause mortality in individuals at high risk of diabetes with normal glucose tolerance, identified by screening: a follow-up study of the Anglo–Danish–Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION), Denmark , 2010, Diabetologia.

[70]  E. Ding,et al.  Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.

[71]  K. Channer,et al.  Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes. , 2006, European journal of endocrinology.

[72]  J. Kielstein,et al.  Glucose levels and risk of dementia. , 2013, The New England journal of medicine.

[73]  M. van Buchem,et al.  Progression of brain atrophy and cognitive decline in diabetes mellitus , 2010, Neurology.

[74]  P. Engström,et al.  Pre-diabetes and diabetes: Medical risk factors and periodontal conditions , 2013, Acta odontologica Scandinavica.

[75]  A Sekikawa,et al.  Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. , 1999, Diabetes care.

[76]  S. Shott,et al.  Type 2 diabetes, glycemic control, and continuous positive airway pressure in obstructive sleep apnea. , 2005, Archives of internal medicine.

[77]  J. Tuomilehto,et al.  Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose. , 2002, European heart journal.

[78]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[79]  J. Moriguti,et al.  (Pre)diabetes, brain aging, and cognition. , 2009, Biochimica et biophysica acta.

[80]  S. Yusuf,et al.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.

[81]  V. Spallone,et al.  Usefulness of ambulatory blood pressure monitoring in predicting the presence of autonomic neuropathy in type I diabetic patients , 2007, Journal of Human Hypertension.

[82]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[83]  Christos Davatzikos,et al.  Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy , 2011, The Lancet Neurology.

[84]  M. Buysschaert,et al.  Definition of prediabetes. , 2011, The Medical clinics of North America.

[85]  Walter C Willett,et al.  Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. , 2002, Diabetes care.

[86]  W. Rathmann,et al.  Older Subjects With Diabetes and Prediabetes Are Frequently Unaware of Having Distal Sensorimotor Polyneuropathy , 2013, Diabetes Care.

[87]  J. Stradling,et al.  Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes , 2007, Thorax.

[88]  L. Bouter,et al.  Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study , 1999, Diabetologia.

[89]  H. Parving,et al.  On the Mechanisms of Blunted Nocturnal Decline in Arterial Blood Pressure in NIDDM Patients With Diabetic Nephropathy , 1995, Diabetes.

[90]  S. Raptis,et al.  Metabolic syndrome and prediabetes identify overlapping but not identical populations. , 2006, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[91]  P. Scheltens,et al.  Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.

[92]  R. Perera,et al.  Prevention of diabetes , 2006, BMJ : British Medical Journal.

[93]  Wolfgang Rathmann,et al.  Prediabetes: a high-risk state for diabetes development , 2012, The Lancet.

[94]  S. Fowler,et al.  The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial , 2005, Annals of Internal Medicine.

[95]  S. Yusuf,et al.  Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET/TRANSCEND research programme. , 2009, Diabetes research and clinical practice.

[96]  M. Buysschaert,et al.  Diagnosis of Prediabetes and Diabetes Prevention , 2013 .

[97]  N. Powe,et al.  Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes. , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[98]  J. Shaw,et al.  Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study , 2009, Diabetologia.

[99]  C. Brayne,et al.  The continuing challenge of turning promising observational evidence about risk for dementia to evidence supporting prevention. , 2014, JAMA internal medicine.

[100]  J. Pankow,et al.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.

[101]  F. J. Ensell,et al.  ATMOSPHERIC OZONE AND FEMORAL FRACTURES , 1975, The Lancet.

[102]  L. Aiello,et al.  Retinopathy in diabetes. , 2004, Diabetes care.

[103]  Jaspinder Kaur A Comprehensive Review on Metabolic Syndrome , 2014, Cardiology research and practice.

[104]  W. White Relevance of blood pressure variation in the circadian onset of cardiovascular events , 2003, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[105]  H. Aldred,et al.  Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes , 2007, Diabetes Care.

[106]  S. Jee,et al.  Adiponectin as predictor for diabetes among pre-diabetic groups , 2013, Endocrine.

[107]  Chin-Lee Wu,et al.  NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. , 2013, Cancer cell.

[108]  F. A. Antonio,et al.  Non-alcoholic fatty liver disease: a diabetologist’s perspective , 2014, Endocrine.

[109]  C. Glueck,et al.  Metabolic syndrome in childhood predicts adult metabolic syndrome and type 2 diabetes mellitus 25 to 30 years later. , 2008, The Journal of pediatrics.

[110]  Martin J Shipley,et al.  Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study. , 2006, Diabetes care.

[111]  小原 知之 Glucose tolerance status and risk of dementia in the community : the Hisayama study , 2011 .

[112]  J. Concato,et al.  Obstructive Sleep Apnea as a Risk Factor for Type 2 , 2009 .

[113]  M. Bergman Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus , 2013, Endocrine.

[114]  C. Agardh,et al.  Day and night variation in ambulatory blood pressure in type 1 diabetes mellitus with nephropathy and autonomic neuropathy , 1993, Journal of internal medicine.

[115]  G. Balercia,et al.  Hormonal association and sexual dysfunction in patients with impaired fasting glucose: a cross-sectional and longitudinal study. , 2012, The journal of sexual medicine.

[116]  E. Tasali,et al.  Obstructive Sleep Apnea and Type 2 Diabetes: Is There a Link? , 2012, Front. Neur..

[117]  J. Danesh,et al.  Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic Review , 2010, PLoS medicine.

[118]  R. Klein,et al.  Association of A1C and Fasting Plasma Glucose Levels With Diabetic Retinopathy Prevalence in the U.S. Population , 2009, Diabetes Care.

[119]  E. Ford,et al.  Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. , 2010, Journal of the American College of Cardiology.

[120]  Peisong Chen,et al.  Prediabetes and the risk of cancer: a meta-analysis , 2014, Diabetologia.

[121]  R. Krauss,et al.  Diagnosis and management of the metabolic syndrome , 2005 .

[122]  S. Anker,et al.  Prediabetes is not an independent risk factor for incident heart failure, other cardiovascular events or mortality in older adults: findings from a population-based cohort study. , 2013, International journal of cardiology.

[123]  T. Kigoshi,et al.  Reversed circadian blood pressure rhythm is associated with occurrences of both fatal and nonfatal vascular events in NIDDM subjects. , 1998, Diabetes.

[124]  Martin Buysschaert,et al.  Diabetes prevention: global health policy and perspectives from the ground. , 2012, Diabetes management.

[125]  S. Haffner,et al.  The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. , 2003, Diabetes care.

[126]  H. Ou,et al.  Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose. , 2012, The Journal of clinical endocrinology and metabolism.

[127]  C. Bogardus,et al.  High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. , 2002, Diabetes.

[128]  S. Srinivasan,et al.  Changes in Risk Variables of Metabolic Syndrome Since Childhood in Pre-Diabetic and Type 2 Diabetic Subjects , 2008, Diabetes Care.

[129]  M. Naharci,et al.  Effect of testosterone on insulin sensitivity in men with idiopathic hypogonadotropic hypogonadism. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[130]  S. Grundy,et al.  Metabolic syndrome and hyperglycemia: congruence and divergence. , 2006, The American journal of cardiology.

[131]  Naresh M Punjabi,et al.  Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. , 2008, Diabetes research and clinical practice.

[132]  V. Montori,et al.  Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. , 2010, The Journal of clinical endocrinology and metabolism.

[133]  D. Einhorn,et al.  Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. , 2007, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[134]  G. Hackett,et al.  Testosterone Deficiency, Cardiac Health, and Older Men , 2014, International journal of endocrinology.

[135]  Tetyana Kendzerska,et al.  Obstructive sleep apnea and incident diabetes. A historical cohort study. , 2014, American journal of respiratory and critical care medicine.

[136]  G. Reaven The insulin resistance syndrome: definition and dietary approaches to treatment. , 2005, Annual review of nutrition.

[137]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[138]  J. Ruidavets,et al.  Relationship Between Markers of Insulin Resistance, Markers of Adiposity, HbA1c, and Cognitive Functions in a Middle-Aged Population–Based Sample: the MONA LISA Study , 2013, Diabetes Care.

[139]  S. Chatterjee,et al.  Impaired fasting glucose and the risk of incident diabetes mellitus and cardiovascular events. , 2011, Journal of the American College of Cardiology.

[140]  N. Punjabi,et al.  Obstructive sleep apnoea and type 2 diabetes mellitus: a bidirectional association. , 2013, The Lancet. Respiratory medicine.

[141]  J. Holst,et al.  Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes? , 2009, Diabetologia.

[142]  S. Fowler,et al.  Long‐term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[143]  L. Sjöström,et al.  The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[144]  P. Koudstaal,et al.  Prevalence of Prediabetes and Newly Diagnosed Diabetes in Patients with a Transient Ischemic Attack or Stroke , 2013, Cerebrovascular Diseases.

[145]  David V. Power,et al.  Standards of Medical Care in Diabetes: Response to position statement of the American Diabetes Association , 2006 .

[146]  M. Woodward,et al.  meta-analysis of 37 prospective cohort studies associated with diabetes in men and women: Excess risk of fatal coronary heart disease , 2006 .

[147]  F. Jaw,et al.  Prediabetes Is Associated with an Increased Risk of Testosterone Deficiency, Independent of Obesity and Metabolic Syndrome , 2013, PloS one.

[148]  Michael E. Miller,et al.  Effect of diabetes on brain structure: the action to control cardiovascular risk in diabetes MR imaging baseline data. , 2014, Radiology.

[149]  S. Raptis,et al.  Early vascular lesions in subjects with metabolic syndrome and prediabetes. , 2006, International angiology : a journal of the International Union of Angiology.

[150]  S. Kanba,et al.  Glucose tolerance status and risk of dementia in the community , 2011, Neurology.

[151]  C. Stehouwer,et al.  Cognitive decline in type 2 diabetes. , 2014, The lancet. Diabetes & endocrinology.

[152]  Hiram Beltrán-Sánchez,et al.  Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. , 2013, Journal of the American College of Cardiology.

[153]  Howard C. Tenenbaum,et al.  Effect of glycemic control on self-perceived oral health, periodontal parameters, and alveolar bone loss among patients with prediabetes. , 2014, The Journal of Periodontology.

[154]  S. Surani,et al.  Effect of continuous positive airway pressure therapy on glucose control. , 2012, World journal of diabetes.

[155]  N. Day,et al.  Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk , 2004, Annals of Internal Medicine.

[156]  Z. Halpern,et al.  Non‐alcoholic fatty liver disease independently predicts prediabetes during a 7‐year prospective follow‐up , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[157]  B. Hoogwerf,et al.  Blood glucose concentrations < or = 125 mg/dl and coronary heart disease risk. , 2002, The American journal of cardiology.

[158]  Kuo-Hsuan Chang,et al.  Effect of pre-diabetes on future risk of stroke: meta-analysis , 2012, BMJ : British Medical Journal.

[159]  M. Jokela,et al.  Accelerated Increase in Serum Interleukin-1 Receptor Antagonist Starts 6 Years Before Diagnosis of Type 2 Diabetes , 2010, Diabetes.

[160]  S. Fowler,et al.  The prevalence of retinopathy in impaired glucose tolerance and recent‐onset diabetes in the Diabetes Prevention Program , 2007, Diabetic medicine : a journal of the British Diabetic Association.

[161]  Beverley Balkau,et al.  articleNine-year incident diabetes is predicted by fatty liver indices : the French D . E . S . I . R . study , 2015 .

[162]  M. Ahmadpanah,et al.  Cognitive processes and functions in patients with type 2 diabetes in comparison to pre-diabetic patients. , 2013, Journal of research in health sciences.

[163]  F. Schick,et al.  α2-Heremans-Schmid Glycoprotein/ Fetuin-A Is Associated With Insulin Resistance and Fat Accumulation in the Liver in Humans , 2006 .

[164]  J. Crandall,et al.  Mechanisms of vascular complications in prediabetes. , 2011, The Medical clinics of North America.

[165]  B. Zinman,et al.  Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. , 2000, Diabetes care.

[166]  E. Feskens,et al.  Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.

[167]  Markolf Hanefeld,et al.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. , 2003, JAMA.

[168]  G. Cornelissen,et al.  Prediabetes is associated with abnormal circadian blood pressure variability , 2008, Journal of Human Hypertension.

[169]  B. Anderson,et al.  Neurocognitive Functioning in Children and Adolescents at the Time of Type 1 Diabetes Diagnosis: Associations With Glycemic Control 1 Year After Diagnosis , 2014, Diabetes Care.

[170]  T. Otsuka,et al.  Two‐hour post‐load plasma glucose levels are associated with carotid intima‐media thickness in subjects with normal glucose tolerance , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[171]  T. Mäkikallio,et al.  Impaired Fasting Plasma Glucose and Type 2 Diabetes Are Related to the Risk of Out-of-Hospital Sudden Cardiac Death and All-Cause Mortality , 2013, Diabetes Care.

[172]  A. Thanopoulou,et al.  Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.

[173]  R. Dankner,et al.  Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches , 2013, Endocrine.

[174]  S. Iyer,et al.  Effect of pioglitazone on metabolic syndrome risk factors: results of double-blind, multicenter, randomized clinical trials* , 2005, Current medical research and opinion.

[175]  R Peto,et al.  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. , 2008, Lancet.

[176]  Clifford R. Jack,et al.  Association of type 2 diabetes with brain atrophy and cognitive impairment , 2014, Neurology.

[177]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[178]  Beverley Balkau,et al.  High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study , 1998, Diabetes Care.

[179]  S. Redline,et al.  Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. , 2004, American journal of epidemiology.

[180]  J. Hardies,et al.  Prevalence of Prediabetes and Diabetes and Metabolic Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD) , 2012, Diabetes Care.

[181]  W. Johnson,et al.  Dysglycemia induces abnormal circadian blood pressure variability , 2011, Cardiovascular diabetology.

[182]  N. Wareham,et al.  Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) , 2001, BMJ : British Medical Journal.

[183]  M. Jokela,et al.  Adiponectin Trajectories Before Type 2 Diabetes Diagnosis , 2012, Diabetes Care.

[184]  M. Kivimaki,et al.  Trajectories of the Framingham general cardiovascular risk profile in midlife and poor motor function later in life: The Whitehall II study☆☆☆ , 2014, International Journal of Cardiology.

[185]  M. Schulze,et al.  Liver Enzymes and Incident Diabetes , 2008, Diabetes Care.

[186]  A. Vinik,et al.  Neuropathy in prediabetes: does the clock start ticking early? , 2011, Nature Reviews Endocrinology.

[187]  J. Danesh,et al.  Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. , 2010, Lancet.

[188]  E. Barrett-Connor,et al.  Metabolic syndrome components and their response to lifestyle and metformin interventions are associated with differences in diabetes risk in persons with impaired glucose tolerance , 2014, Diabetes, obesity & metabolism.

[189]  C. Sumner,et al.  The spectrum of neuropathy in diabetes and impaired glucose tolerance , 2003, Neurology.

[190]  Y. Ohashi,et al.  Fasting and post-challenge glucose as quantitative cardiovascular risk factors: a meta-analysis. , 2012, Journal of atherosclerosis and thrombosis.

[191]  T. Cukierman-Yaffe Diabetes, dysglycemia and cognitive dysfunction , 2014, Diabetes/metabolism research and reviews.

[192]  P. Calverley,et al.  Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. , 2004, European heart journal.

[193]  Ekrem Orbay,et al.  Association of Nonalcoholic Fatty Liver Disease With Insulin Resistance: Is OGTT Indicated in Nonalcoholic Fatty Liver Disease? , 2003, Journal of clinical gastroenterology.

[194]  G. Roglić,et al.  Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. , 2014, The lancet. Diabetes & endocrinology.

[195]  Allan Vaag,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[196]  S. Grundy Pre-diabetes, metabolic syndrome, and cardiovascular risk. , 2012, Journal of the American College of Cardiology.

[197]  N. Bissada,et al.  Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. , 1981, Journal of periodontology.

[198]  M. Bergman,et al.  Inadequacies of current approaches to prediabetes and diabetes prevention , 2013, Endocrine.

[199]  M. Kubo,et al.  Liver Enzymes as a Predictor for Incident Diabetes in a Japanese Population: The Hisayama Study , 2007, Obesity.

[200]  John A Spertus,et al.  Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Executive Summary , 2005, Critical pathways in cardiology.

[201]  B. Zinman,et al.  Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. , 2004, Diabetes.

[202]  J. Shaw,et al.  Risk of Cardiovascular and All-Cause Mortality in Individuals With Diabetes Mellitus, Impaired Fasting Glucose, and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) , 2007, Circulation.

[203]  A. Hamsten,et al.  Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study , 2002, The Lancet.

[204]  Cynthia Balion,et al.  Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. , 2007, Diabetes research and clinical practice.

[205]  A. Folsom,et al.  Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study. , 2005, Archives of internal medicine.

[206]  E. Sarchielli,et al.  Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. , 2009, The journal of sexual medicine.

[207]  H. Tilg,et al.  Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis , 2010, Hepatology.

[208]  B. Howard,et al.  Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample: The Strong Heart Study , 2006, Hypertension.

[209]  R. DeFronzo,et al.  Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. , 2011, The American journal of cardiology.

[210]  S. Yusuf,et al.  Effect of ramipril and of rosiglitazone on carotid intima-media thickness in people with impaired glucose tolerance or impaired fasting glucose: STARR (STudy of Atherosclerosis with Ramipril and Rosiglitazone). , 2009, Journal of the American College of Cardiology.

[211]  Michael E. Miller,et al.  Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. , 2014, JAMA internal medicine.

[212]  S. Arver,et al.  Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study) , 2011, Diabetes Care.

[213]  K. Yamagishi,et al.  Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS) , 2010, Diabetologia.

[214]  S. Fowler,et al.  Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. , 2005, Diabetes care.

[215]  P. Allhoff,et al.  The Framingham Offspring Study , 1991 .

[216]  M. Kivimäki,et al.  Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study , 2014, The lancet. Diabetes & endocrinology.

[217]  Anna Castiglione,et al.  The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population , 2006, BMC gastroenterology.

[218]  Victor M Montori,et al.  Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. , 2007, Journal of the American College of Cardiology.

[219]  Edward Giovannucci,et al.  Diabetes and Cancer , 2010, Diabetes Care.

[220]  A. Sharrett,et al.  Glycated haemoglobin and cognitive decline: the Atherosclerosis Risk in Communities (ARIC) study , 2011, Diabetologia.

[221]  H. Ellingsgaard,et al.  Islet Inflammation in Type 2 Diabetes , 2008, Diabetes Care.

[222]  C. Meisinger,et al.  Categories of glucose tolerance and continuous glycemic measures and mortality , 2011, European Journal of Epidemiology.

[223]  R. DeFronzo,et al.  Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease , 1991, Diabetes Care.

[224]  Elizabeth Selvin,et al.  Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study. , 2014, The lancet. Diabetes & endocrinology.

[225]  Sujoy Ghosh,et al.  [Retinopathy in prediabetes]. , 2010, MMW Fortschritte der Medizin.

[226]  David B Sacks,et al.  A new look at screening and diagnosing diabetes mellitus. , 2008, The Journal of clinical endocrinology and metabolism.

[227]  F. Chan,et al.  Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non‐alcoholic fatty liver disease , 2006, Alimentary pharmacology & therapeutics.

[228]  S. Piro,et al.  Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria , 2014, Diabetes Care.

[229]  W. Rathmann,et al.  Association between Markers of Fatty Liver Disease and Impaired Glucose Regulation in Men and Women from the General Population: The KORA-F4-Study , 2011, PloS one.

[230]  Peter Lindgren,et al.  Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary , 2007 .

[231]  G. Curhan Prediabetes, prehypertension ... is it time for pre-CKD? , 2010, Clinical journal of the American Society of Nephrology : CJASN.

[232]  J. Tuomilehto,et al.  Cardiovascular Disease Mortality in Europeans in Relation to Fasting and 2-h Plasma Glucose Levels Within a Normoglycemic Range , 2010, Diabetes Care.

[233]  Gabi Kastenmüller,et al.  Early Metabolic Markers of the Development of Dysglycemia and Type 2 Diabetes and Their Physiological Significance , 2013, Diabetes.